20Nov 2019

EMERGENCE OF IMIPENEM RESISTANT ACINETOBACTER BAUMANNII ISOLATES FROM VARIOUS CLINICAL SAMPLES IN A TERTIARY CARE HOSPITAL IN KANCHIPURAM DISTRICT

  • Department of Microbiology, Sri Muthukumaran Medical College Hospital and Research Institute, Dr. M.G.R Medical University, Chikkarayapuram, Chennai, Tamil Nadu, India
  • Department of Microbiology, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Thandalam, Chennai, Tamil Nadu, India
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Acinetobacter is an important opportunistic pathogen and is a common cause of hospital acquired infections including bacteremia, pneumonia, urinary tract infection, peritonitis, etc. In the recent past carbapenems had been drugs of choice for serious infections with Acinetobacter baumannii, but imipenem resistant strains are rapidly emerging. Objectives: The aim of the study was to determine the prevalence of imipenem resistant Acinetobacter baumannii(IRAB) isolates from various clinical samples in a tertiary care hospital. Methods: A total of 734 samples were collected over a period of one year from November 2017 to November 2018. Bacterial isolates were identified using standard methods. Antibiotic susceptibility testing was done by Kirby Bauer disc diffusion method according to the Clinical and Laboratory Standards Institute(CLSI) guidelines. Results: Of 734 specimens, 191 (26%) were Acinetobacter baumannii. Among the Acinetobacter baumannii isolates 93 (49%) were resistant to imipenem. Isolates were predominantly from males(56%) followed by females(44%). Maximum number of Acinetobacter baumannii were from urine samples 67(35%), followed by pus 43(23%), sputum 37(19%), miscellaneous (body fluids and others) 29(15%) and blood 16(8%). Imipenem Resistant Acinetobacter baumannii (IRAB)were from urine samples 31(33%), followed by pus 22(24%), sputum 18(19%), miscellaneous (body fluids and others) 15(16%) and blood 7(8%). Conclusion: This study highlights the high prevalence of imipenem resistant Acinetobacter baumannii among clinical samples. The emergence of IRAB is a serious global threat to public health. Hence there is a need for strict infection control and monitoring of antimicrobial therapy to combat infections caused by IRAB

  1. Gautam V, Singhal L, Ray P. (2011): Burkholoderia cepacia complex. Beyond Pseudomonas and Acinetobacter. Ind J Med Microbiol, 29:4-12.
  2. Vishnu Preya and R. Nepoleon. (2019): Analysis of Carbapenem Susceptibility Pattern among Acinetobacter isolates in a Tertiary Care Hospital, india. Int.J.Curr.Microbiol. App.Sci 8(3): 1423-1429.
  3. Yu YS, Yang Q, Xu XW, Kong HS, Xu GY, Zhong BY. (2004): Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus‑baumannii complex in a Chinese hospital. J Med Microbiol, 53: 653-6.
  4. Saranya Vijayakuma, Purva Mathur, Arti Kapil et al., (2019) : Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii. Indian J Med Res, pp 240-246.
  5. Tille PM. Bailey and Scott?s Diagnostic Microbiology, 13th edition. (2014): St. Louis, Missouri: Elsevier, 193-231.
  6. Bauer AW, Kirby WM, Sherris JC, Turck M. (1966): Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol, 45:493-6.
  7. Clinical Laboratory Standards Institutes (CLSI). (2016): Performance standards for antimicrobial susceptibility testing. 26th ed. CLSI supplement M100S. Wayne, PA: Clinical and Laboratory Standards Institute, Jan;36(1):40-256
  8. Tang SS, Apisarnthanarak A, Hsu LY. (2014): Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community-and healthcare-associated multidrug-resistant bacteria. .?Adv Drug Deliv Rev,78:3?13.
  9. Nadheema Hammood Hussein, Harith Jabbar Fahad Al-Mathkhury and Majeed Arsheed Sabbah. (2013): Imipenem-Resistant Acinetobacter baumannii isolated from patients and hospitals environment in Baghdad. Iraqi Journal of Science, Vol 54, No.4, pp:803-812.
  10. Anuradha, Muthulakshmi, Somasunder.(2015): Phenotypic characterization of Acinetobacter from various clinical samples and molecular study on imipenem resistant strains in a tertiary care hospital, Enathur, Kanchipuram. European J Pharmaceutical Med Res,2(6):314.
  11. Lone R, Shah A, Kadri SM, Lone S, Faisal S. (2009): Nosocomial Multi‑Drug‑Resistant Acinetobacter Infections ? Clinical Findings. Risk Factors and Demographic Characteristics. Bangladesh J Med Microbiol, 3:34‑
  12. Manikal V M, D Landman, G Saurina, E Oydna, H Lal and J Quale. (2000): Endemic carbapenem resistant Acinetobacter species in brooklyn, New York: City wilde prevalence. Inter-institutional spread, and relation to antibiotic usage. ClinInfec Dis, 31:101-106.
  13. Fiji E, B Anandharaj. (2018): Regional Prevalence and Evaluation of Carbapenem Resistant baumannii. International Journal of Pharmaceutical and Clinical Research, 10(9): 234-237 ISSN- 0975 1556.
  14. Gaur A, Garg A, Prakash P, Anupurba S, Mohapatra TM. (2008): Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India. J Health Popul Nutr, 26(2): 183-8.
  15. Amarjeet Kaur , Veenu Gupta, Deepinder Chhina. (2014) Prevalence of metallo- β-lactamase-producing (MBL) Acinetobacter species in a tertiary care hospital IRAN. J. Microbiol. Vol. 6, No. 1, 22-25.
  16. Kabbaj H, Seffar M, Belefquih B, Akka D, Handor N, Amor M et al., (2013): Prevalence of Metallo-βLactamases Producing Acinetobacter baumannii in a moroccan Hospital. ISRN Infectious Diseases. Article ID 154921, 3 pages www.hindawi.com/isrn/ id/2013/154921.
  17. Jean Uwingabiye, Mohammed Frikh, Abdelhay Lemnouer et al.,(2016): Acinetobacter infections prevalence and frequency of the antibiotics resistance: comparative study of intensive care units versus other hospital units ThePanAfrican Medical Journal, 23:191.
  18. Anitha, DM. Monisha, A. Mohamed Sulthan, Sathya Pandurangan. (2016): Emergence and Prevalence of Acinetobacter baumannii in Tertiary Care Hospital Settings. Sch. Acad. J. Biosci., (SAJB), 4(4A):335-341.

[M. Anitha, Sumathi G, P.A.T. Jagatheeswary and Nithyalakshmi Jayakumar (2019); EMERGENCE OF IMIPENEM RESISTANT ACINETOBACTER BAUMANNII ISOLATES FROM VARIOUS CLINICAL SAMPLES IN A TERTIARY CARE HOSPITAL IN KANCHIPURAM DISTRICT Int. J. of Adv. Res. 7 (Nov). 542-547] (ISSN 2320-5407). www.journalijar.com

M.Anitha
Department of Microbiology, Sri Muthukumaran Medical College Hospital and Research Institute, Dr. M.G.R Medical University, Chikkarayapuram, Chennai, Tamil Nadu, India.

DOI:

Article DOI: 10.21474/IJAR01/10043      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10043

Download Full Paper

Download PDF No. of Downloads: 11 | No. of Views: 39